According to Edward Dowd on Twitter, the United States has cancelled more than $700 million in funding for Moderna's bird flu vaccine, as reported by Reuters. This significant funding cut could negatively affect Moderna's stock (MRNA) and has led to increased volatility in biotech sector equities. For crypto traders, this move may drive capital flows out of biotech stocks into alternative assets like Bitcoin and Ethereum, as investors seek diversification amid rising uncertainty in traditional markets (Source: Reuters, May 28, 2025).